Literature DB >> 9278647

Lymph node metastasis in carcinoma of the body and tail of the pancreas.

A Nakao1, A Harada, T Nonami, T Kaneko, S Nomoto, H Koyama, N Kanazumi, N Nakashima, H Takagi.   

Abstract

BACKGROUND: There have been no precise reports concerning lymph node metastatic involvement in carcinoma of the body and tail of the pancreas.
METHODS: Histopathological examination of lymph node involvement in 30 specimens obtained from patients who underwent pancreatic resection and wide dissection of lymph nodes, including para-aortic lymph nodes, for carcinoma of the body and tail of the pancreas was performed.
RESULTS: Fourteen of 30 patients had lymph node involvement. The highest incidence of lymph node involvement was around the splenic artery (five of 30 patients), aorta (four of 30) and coeliac trunk (four of 30). No significant difference in survival rate between the lymph node-negative group and the lymph node-positive group was observed, but all patients in the positive group died within 2 years after surgery, and four patients with para-aortic lymph node involvement died from recurrence within 10 months after surgery. Survival rates were significantly worse in patients with histopathological extrapancreatic nerve plexus invasion, retropancreatic tissue invasion, tumour diameter more than 4 cm, histological portal system vein wall invasion and carcinoma invasion of the surgical margins.
CONCLUSION: Although aggressive extended surgery including para-aortic node dissection has been performed, the postoperative survival rate is still low in patients with carcinoma of the body and tail of the pancreas. The high incidence of liver metastasis after surgery is a prime cause of the poor outcome, and effective therapy for postoperative liver recurrence requires evaluation.

Entities:  

Mesh:

Year:  1997        PMID: 9278647     DOI: 10.1046/j.1365-2168.1997.02754.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  21 in total

Review 1.  Oncological problems in pancreatic cancer surgery.

Authors:  Akimasa Nakao; Tsutomu Fujii; Hiroyuki Sugimoto; Naohito Kanazumi; Shuji Nomoto; Yasuhiro Kodera; Soichiro Inoue; Shin Takeda
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

2.  Indications and techniques of extended resection for pancreatic cancer.

Authors:  Akimasa Nakao; Shin Takeda; Soichiro Inoue; Shuji Nomoto; Naohito Kanazumi; Hiroyuki Sugimoto; Tsutomu Fujii
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

3.  Resection of non-cystic adenocarcinoma in pancreatic body and tail.

Authors:  Hai-Chao Yan; Yu-Lian Wu; Li-Rong Chen; Shun-Liang Gao
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

4.  Extended resection for pancreatic adenocarcinoma.

Authors:  T M van Gulik; A Nakao; H Obertop
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

5.  Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasuo Hayashidani; Yasushi Hashimoto; Hiroki Ohge; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2008-08-13       Impact factor: 3.452

6.  CT and MR imaging patterns for pancreatic carcinoma invading the extrapancreatic neural plexus (Part I): Anatomy, imaging of the extrapancreatic nerve.

Authors:  Hou-Dong Zuo; Xiao-Ming Zhang; Cheng-Jun Li; Chang-Ping Cai; Qiong-Hui Zhao; Xing-Guo Xie; Bo Xiao; Wei Tang
Journal:  World J Radiol       Date:  2012-02-28

7.  Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer.

Authors:  Suguru Yamada; Tsutomu Fujii; Akihiro Hirakawa; Mitsuro Kanda; Hiroyuki Sugimoto; Yasuhiro Kodera
Journal:  Langenbecks Arch Surg       Date:  2016-04-05       Impact factor: 3.445

8.  Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence.

Authors:  Wenjie Sun; Cheng N Leong; Zhen Zhang; Jiade J Lu
Journal:  Radiat Oncol       Date:  2010-04-15       Impact factor: 3.481

9.  Long-term results and prognostic factors in resected pancreatic body and tail adenocarcinomas.

Authors:  Vinayak S Rohan; Jun-Te Hsu; Keng-Hao Liu; Chun-Nan Yeh; Ta-Sen Yeh; Yi-Yin Jan; Tsann-Long Hwang
Journal:  J Gastrointest Cancer       Date:  2013-03

10.  Prognostic factors in patients with pancreatic cancer.

Authors:  DE-Xiang Zhang; Yue-DI Dai; Su-Xu Yuan; Li Tao
Journal:  Exp Ther Med       Date:  2011-12-08       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.